Acetic Acid

Acetic Acid

SCHEMBL3684341

CC(=O)[O-].CCC[N+](C)(C)C

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 known ✓ P30926 1/20 0.42
CHRNA3 known ✓ P32297 1/20 0.42
ADRA2A known ✓ P08913 1/20 0.37
CA1 P00915 2/20 0.44
ACHE P22303 1/20 0.44
CHRM5 P08912 2/20 0.42
CHRM1 P11229 2/20 0.42
CHRM3 P20309 2/20 0.42
PGR P06401 1/20 0.42
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
HTR1A P08908 1/20 0.42
CHRNB2 P17787 1/20 0.42
TBXA2R P21731 1/20 0.42
CHRNA7 P36544 1/20 0.42
CHRNA4 P43681 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CHRNA10 Q9GZZ6 1/20 0.42
CHRNA9 Q9UGM1 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL1896982 0.92 BBOX1 (0.43) ACHECHRM5CHRM1CHRM3PGR
Bicarbonate SCHEMBL10697126 0.89 BBOX1 (0.42) ACHECHRM5CHRM1CHRM3PGR
Bicarbonate SCHEMBL9499506 0.89 BBOX1 (0.42) ACHECHRM5CHRM1CHRM3PGR
Propionic Acid SCHEMBL5573582 0.86 BBOX1 (0.45) CA1ACHECYP2C19BBOX1FFAR3
Methacrylic Acid SCHEMBL4926692 0.85 ACHE (0.38) ACHECHRM5CHRM1CHRM3PGR
Acetic Acid SCHEMBL11665147 0.85 CA1 (0.53) CA1ACHECHRM5CHRM1CHRM3
Acetic Acid SCHEMBL5574141 0.84 DNM1 (0.52) CA1ACHESMN1; SMN2RAB9ADNM1
Methacrylic Acid SCHEMBL5175782 0.84 CHRM5 (0.39) ACHECHRM5CHRM1CHRM3PGR
Acetic Acid SCHEMBL557807 0.83 CA1 (0.44) CA1ACHEBBOX1FFAR3HDAC3
Acetic Acid SCHEMBL27957649 0.83 DNM1 (0.46) CA1BBOX1FFAR3HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021130848-A1 METHOD FOR PRODUCING SILYL ETHERIFIED PRODUCT OF POLYSACCHARIDE 国立大学法人金沢大学 2021-07-01 WO disclosed
US-10087155-B2 Onium salt, liquid composition containing said onium salt and cellulose, and cellulose recovery method KOEI CHEMICAL COMPANY, LIMITED (JP) 2018-10-02 US disclosed
EP-3170789-B1 PRODUCTION PROCESS FOR FLUOROSULFONYLIMIDE AMMONIUM SALT NIPPON SODA CO (JP) 2018-04-18 EP disclosed
EP-3170789-A1 PRODUCTION PROCESS FOR FLUOROSULFONYLIMIDE SALT NIPPON SODA CO., LTD. (JP) 2017-05-24 EP disclosed
US-9242862-B2 Process for production of fluorosulfonylimide ammonium salt NIPPON SODA CO., LTD. (JP) 2016-01-26 US disclosed
US-20160009669-A1 ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD KOEI CHEMICAL COMPANY, LIMITED (JP) 2016-01-14 US disclosed
US-9096502-B2 Production process for fluorosulfonylimide ammonium salt NIPPON SODA CO., LTD. (JP) 2015-08-04 US disclosed
EP-2674395-A1 PROCESS FOR PRODUCTION OF FLUOROSULFONYLIMIDE AMMONIUM SALT Nippon Soda Co., Ltd. (JP) 2013-12-18 EP disclosed
US-20130331609-A1 PRODUCTION PROCESS FOR FLUOROSULFONYLIMIDE AMMONIUM SALT NIPPON SODA CO., LTD. (JP) 2013-12-12 US disclosed
US-20130323154-A1 PROCESS FOR PRODUCTION OF FLUOROSULFONYLIMIDE AMMONIUM SALT NIPPON SODA CO., LTD. (JP) 2013-12-05 US disclosed
EP-2660196-A1 MANUFACTURING METHOD FOR FLUOROSULFONYLIMIDE AMMONIUM SALT Nippon Soda Co., Ltd. (JP) 2013-11-06 EP disclosed
US-8410150-B2 Inhibitors of carnitine palmitoyltransferase and treating cancer UNIVERSITY HEALTH NETWORK (CA) 2013-04-02 US disclosed
US-20100105900-A1 INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER UNIVERSITY HEALTH NETWORK 2010-04-29 US disclosed
US-20070135565-A1 COMPOSITION FOR FORMING POROUS FILM, POROUS FILM AND METHOD FOR FORMING THE SAME, INTERLEVEL INSULATOR FILM, AND SEMICONDUCTOR DEVICE MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2007-06-14 US disclosed
US-7132473-B2 Composition for forming porous film, porous film and method for forming the same, interlevel insulator film, and semiconductor device MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2006-11-07 US disclosed
EP-1568744-A1 COMPOSITION FOR POROUS FILM FORMATION, POROUS FILM, PROCESS FOR PRODUCING THE SAME, INTERLAYER INSULATION FILM AND SEMICONDUCTOR DEVICE MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2005-08-31 EP disclosed
US-20040219372-A1 Composition for forming porous film, porous film and method for forming the same, interlevel insulator film, and semiconductor device MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. 2004-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130331609-A1 PRODUCTION PROCESS FOR FLUOROSULFONYLIMIDE AMMONIUM SALT NPEPPS, DNPEP, FOS CHRNB4 4806/4885CHRNA3 4782/4885ADRA2A 4730/4885
US-20160009669-A1 ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD CEL, CROCC, ALG1 CHRNB4 2064/4885CHRNA3 1666/4885ADRA2A 4441/4885
US-20100105900-A1 INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER CPT1A, CPT1B, CPT2 CHRNB4 4774/4885CHRNA3 4595/4885ADRA2A 2720/4885
US-20130323154-A1 PROCESS FOR PRODUCTION OF FLUOROSULFONYLIMIDE AMMONIUM SALT ASNS, NHERF1, NAAA CHRNB4 4627/4885CHRNA3 4522/4885ADRA2A 4721/4885
US-10087155-B2 Onium salt, liquid composition containing said onium salt and cellulose, and cellulose recovery method CEL, CROCC, ALG1 CHRNB4 2064/4885CHRNA3 1666/4885ADRA2A 4441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.